289 related articles for article (PubMed ID: 32785828)
21.
Kim M; Tran P; Yin J; Song J; Kim H
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839177
[TBL] [Abstract][Full Text] [Related]
22. Heat-Killed and Live
Choi YJ; Fan M; Tang Y; Iwasa M; Han KI; Lee H; Hwang JY; Lee B; Kim EK
J Microbiol Biotechnol; 2021 Aug; 31(8):1134-1143. PubMed ID: 34226410
[TBL] [Abstract][Full Text] [Related]
23. Biochemical and histomorphological changes in testosterone propionate-induced benign prostatic hyperplasia in male Wistar rats treated with ketogenic diet.
Kayode OT; Owolabi AV; Kayode AAA
Biomed Pharmacother; 2020 Dec; 132():110863. PubMed ID: 33113424
[TBL] [Abstract][Full Text] [Related]
24. Effects of Melandrium firmum methanolic extract on testosterone-induced benign prostatic hyperplasia in Wistar rats.
Lee MY; Shin IS; Seo CS; Lee NH; Ha HK; Son JK; Shin HK
Asian J Androl; 2012 Mar; 14(2):320-4. PubMed ID: 22231294
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effects of
Choi YJ; Fan M; Wedamulla NE; Tang Y; Bae SM; Hwang JY; Kim EK
Food Funct; 2022 Oct; 13(19):10235-10247. PubMed ID: 36124918
[No Abstract] [Full Text] [Related]
26. Bushen Tongluo formula ameliorated testosterone propionate-induced benign prostatic hyperplasia in rats.
Gong GY; Xi SY; Li CC; Tang WL; Fu XM; Huang YP
Phytomedicine; 2023 Nov; 120():155048. PubMed ID: 37651753
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effects of Ponciri Fructus on testosterone-induced benign prostatic hyperplasia in rats.
Jeon WY; Kim OS; Seo CS; Jin SE; Kim JA; Shin HK; Kim YU; Lee MY
BMC Complement Altern Med; 2017 Aug; 17(1):384. PubMed ID: 28774334
[TBL] [Abstract][Full Text] [Related]
28. Uvaria rufa Blume attenuates benign prostatic hyperplasia via inhibiting 5α-reductase and enhancing antioxidant status.
Buncharoen W; Saenphet K; Saenphet S; Thitaram C
J Ethnopharmacol; 2016 Dec; 194():483-494. PubMed ID: 27732901
[TBL] [Abstract][Full Text] [Related]
29. Auraptene nanoparticles ameliorate testosterone-induced benign prostatic hyperplasia in rats: Emphasis on antioxidant, anti-inflammatory, proapoptotic and PPARs activation effects.
Almukadi H; Eid BG; Shaik RA; Abdel-Naim AB; Esmat A
Biomed Pharmacother; 2021 Nov; 143():112199. PubMed ID: 34649341
[TBL] [Abstract][Full Text] [Related]
30. Role of PPAR-α agonist fenofibrate in the treatment of induced benign prostatic hyperplasia with dysplastic changes in rats.
Refaie MMM; Rifaai RA; Zenhom NM
Fundam Clin Pharmacol; 2018 Dec; 32(6):617-626. PubMed ID: 29862557
[TBL] [Abstract][Full Text] [Related]
31. Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats.
Al-Trad B; Aljabali A; Al Zoubi M; Shehab M; Omari S
Int J Nanomedicine; 2019; 14():3145-3154. PubMed ID: 31118628
[No Abstract] [Full Text] [Related]
32. Berberine ameliorates testosterone-induced benign prostate hyperplasia in rats.
Shabani E; Kalantari H; Kalantar M; Goudarzi M; Mansouri E; Kalantar H
BMC Complement Med Ther; 2021 Dec; 21(1):301. PubMed ID: 34930229
[TBL] [Abstract][Full Text] [Related]
33. Pao Pereira Extract Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by inhibiting 5α-Reductase.
Liu J; Fang T; Li M; Song Y; Li J; Xue Z; Li J; Bu D; Liu W; Zeng Q; Zhang Y; Yun S; Huang R; Yan J
Sci Rep; 2019 Dec; 9(1):19703. PubMed ID: 31873149
[TBL] [Abstract][Full Text] [Related]
34. Effect of diallyl sulfide on in vitro and in vivo Nrf2-mediated pulmonic antioxidant enzyme expression via activation ERK/p38 signaling pathway.
Ho CY; Cheng YT; Chau CF; Yen GC
J Agric Food Chem; 2012 Jan; 60(1):100-7. PubMed ID: 22118872
[TBL] [Abstract][Full Text] [Related]
35. Potential ameliorative effects of epigallocatechin‑3‑gallate against testosterone-induced benign prostatic hyperplasia and fibrosis in rats.
Zhou J; Lei Y; Chen J; Zhou X
Int Immunopharmacol; 2018 Nov; 64():162-169. PubMed ID: 30179845
[TBL] [Abstract][Full Text] [Related]
36. Diallyl sulfide alleviates cisplatin-induced nephrotoxicity in rats via suppressing NF-κB downstream inflammatory proteins and p53/Puma signalling pathway.
Elkhoely A; Kamel R
Clin Exp Pharmacol Physiol; 2018 Jun; 45(6):591-601. PubMed ID: 29266336
[TBL] [Abstract][Full Text] [Related]
37. Diacerein provokes apoptosis, improves redox balance, and downregulates PCNA and TNF-α in a rat model of testosterone-induced benign prostatic hyperplasia: A new non-invasive approach.
Rasheed RA; Sadek AS; Khattab RT; Elkhamisy FAA; Abdelfattah HA; Elshaer MMA; Almutairi SM; Hussein DS; Embaby AS; Almoatasem MAM
PLoS One; 2023; 18(11):e0293682. PubMed ID: 37943844
[TBL] [Abstract][Full Text] [Related]
38. Hesperidin ameliorates benign prostatic hyperplasia by attenuating cell proliferation, inflammatory response, and epithelial-mesenchymal transition via the TGF-β1/Smad signaling pathway.
Kim HJ; Jin BR; An HJ
Biomed Pharmacother; 2023 Apr; 160():114389. PubMed ID: 36791565
[TBL] [Abstract][Full Text] [Related]
39. Carica papaya leaf extract inhibits prostatitis-associated prostatic hyperplasia via the TRAF6/TAK1/MEK/NF-κB pathway.
Jin BR; Ju JY; Nugroho A; Lee M; An HJ
Biomed Pharmacother; 2021 Mar; 135():111197. PubMed ID: 33433362
[TBL] [Abstract][Full Text] [Related]
40. Cynomorium songaricum Rupr demonstrates phytoestrogenic or phytoandrogenic like activities that attenuates benign prostatic hyperplasia via regulating steroid 5-α-reductase.
Tao R; Miao L; Yu X; Orgah JO; Barnabas O; Chang Y; Liu E; Fan G; Gao X
J Ethnopharmacol; 2019 May; 235():65-74. PubMed ID: 30708032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
